Effects of Short-Term Glucocorticoids on Cardiovascular Biomarkers
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
CONTEXT: Glucocorticoids are known to acutely increase blood pressure, suppress inflammation, and precipitate insulin resistance. However, the short-term effects of glucocorticoids on other cardiovascular risk factors remain incompletely characterized. OBJECTIVE: Our objective was to determine the effects of a short course of dexamethasone on multiple cardiovascular biomarkers and to determine whether suppression of morning cortisol in response to low-dose dexamethasone is correlated with cardiovascular risk markers in healthy volunteers. DESIGN: We conducted a randomized, double-blind, placebo-controlled study. SETTING: The study took place in a tertiary care hospital. STUDY SUBJECTS: Twenty-five healthy male volunteers, ages 19-39 yr, participated in the study. INTERVENTION: Subjects received either 3 mg dexamethasone twice daily or placebo for 5 d. Subjects also underwent a low-dose (0.5 mg) overnight dexamethasone suppression test. MEASURES: Parameters examined before and after the 5-d intervention included heart rate, blood pressure, weight, fasting lipid variables, homocysteine, renin, aldosterone, insulin resistance (homeostasis model assessment), high-sensitivity C-reactive protein, B-type natriuretic peptide, flow-mediated and nitroglycerin-mediated brachial artery dilatation, and heart rate recovery after exercise. All measurements were done in the morning hours in the fasting state. RESULTS: Dexamethasone increased systolic blood pressure, weight, B-type natriuretic peptide, and high-density-lipoprotein-cholesterol. Dexamethasone decreased resting heart rate, high-sensitivity C-reactive protein, and aldosterone and tended to attenuate nitroglycerin-mediated vasodilatation. There was no effect on flow-mediated vasodilatation, diastolic blood pressure, triglycerides, low-density-lipoprotein-cholesterol, nonesterified fatty acids, homocysteine, or heart rate recovery. The response of circulating cortisol to low-dose dexamethasone had no significant correlation with any of the cardiovascular risk markers. CONCLUSIONS: Short-term glucocorticoids elicits both favorable and unfavorable effects on different cardiovascular risk factors. Manipulation of specific glucocorticoid-responsive physiological pathways deserves further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083 · cited 1×
“T HE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) axis is vital for survival in stressful situations such as hemorrhage and sepsis (1).”
BackgroundHeart-rate Recovery Immediately After Exercise as a Predictor of Mortality
Cole, C. R., Blackstone, E. H., Pashkow, F. J., Snader, C. E., & Lauer, M. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910283411804 · Cited by 1,935 · cited 1×
“Heart rate recovery was defined as the peak heart rate (at the termination of exercise) minus the heart rate 1 min into the recovery phase of the Bruce protocol (37).”
MethodReaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435 · cited 1×
“Although hyperinsulinemia during a euglycemic clamp is associated with increased sympathetic tone (44), it is possible that this is caused in part by depletion of other circulating substrates from the circulation, such as fatty acids, protein or potassium, rather than from hyperinsulinemia itself.”
BackgroundDoes central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Ramipril and the Development of Diabetes
Yusuf, S. (2001) · JAMA · doi:10.1001/jama.286.15.1882 · Cited by 541 · cited 1×
“Additionally, the mineralocorticoid effects of the steroids used in these other studies may have affected lipid parameters, given the known metabolic effects of drugs affecting the renin-angiotensin-aldosterone system (42, 43).”
BackgroundFaggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021558 · Cited by 358 · cited 1×
“Conversely, exogenous or endogenous glucocorticoid excess can contribute to the development of hypertension, insulin resistance, hyperglycemia, weight gain, hyperhomocysteinemia, and atherosclerosis (3–6).”
BackgroundDoes altered glucocorticoid homeostasis increase cardiovascular risk?
GIROD, J., & BROTMAN, D. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.07.006 · Cited by 193 · cited 2×
“In recent years, a growing body of literature suggests that altered endogenous glucocorticoid homeostasis may contribute to the metabolic syndrome and adverse cardiovascular outcomes (11–18), whereas other studies have suggested salutary effects of glucocorticoids on the cardiovascular system (19).”
BackgroundSelf-citationFRIEDMAN, T. C., MASTORAKOS, G., NEWMAN, T. D., MULLEN, N. M., HORTON, E. G., COSTELLO, R., PAPADOPOULOS, N. M., & CHROUSOS, G. P. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.645 · Cited by 145
TASKINEN, M.-R., KUUSI, T., YKI-JÄARVINEN, & NIKKILÄ, E. A. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-2-291 · Cited by 47
Bruno, A., Carucci, P., Cassader, M., Cavallo-Perin, P., Gruden, G., Olivetti, C., & Pagano, G. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00191902 · Cited by 13
Cited by
The cardiovascular toll of stress
Brotman, D. J., Golden, S. H., & Wittstein, I. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61305-1 · Cited by 713
Self-citationCardiovascular consequences of cortisol excess
Whitworth, J. A., Williamson, P. M., Mangos, G., & Kelly, J. J. (2005) · Vascular Health and Risk Management · doi:10.2147/vhrm.2005.1.4.291 · Cited by 392
Glucocorticoids and cardiovascular events in rheumatoid arthritis: A population‐based cohort study
Davis, J. M., Maradit Kremers, H., Crowson, C. S., Nicola, P. J., Ballman, K. V., Therneau, T. M., Roger, V. L., & Gabriel, S. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22418 · Cited by 233
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers
Brotman, D. J., Girod, J. P., Posch, A., Jani, J. T., Patel, J. V., Gupta, M., Lip, G. Y. H., Reddy, S., & Kickler, T. S. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.06.006 · Cited by 173
“Further information on the study design has been published previously [32].”
BackgroundSelf-citationBevans, K., Cerbone, A., & Overstreet, S. (2008) · Development and Psychopathology · doi:10.1017/s0954579408000126 · Cited by 110
Metadata
- Authors
- Brotman, D. J., Girod, J. P., Garcia, M. J., Patel, J. V., Gupta, M., Posch, A., Saunders, S., Lip, G. Y. H., Worley, S., & Reddy, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-06
- Volume
- 90
- Issue
- 6
- Pages
- 3202-3208
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1997927002
- Cited by
- 117
- References
- 11
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.